Skip to main content
Premium Trial:

Request an Annual Quote

Novartis Venture Fund Supports 23 Biomed, Bioinformatics Startups

Premium

BASEL, Switzerland--Francois L'Eplattenier, chairman of the supervisory board for the Novartis Venture Fund, said he was surprised by the sheer number and remarkable quality of formal proposals the group received in 1997. From 120 proposed projects, the group selected 29 to back, 23 of which are start-up biomedical or bioinformatics companies. The fund reported providing 28 million Swiss francs in participation, loans, one-off payments, or bank guarantees, creating 150 jobs last year and a projected 250 over the next two. In accordance with the fund's initial intent to support employees whose activities are no longer part of Novartis's core business, 22 of the 23 startups it supported involve former Novartis or Ciba Specialty Chemicals employees.

Filed under

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.